Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

Natural Resource Partners L.P. plans to report its fourth quarter and full year 2024 financial results before the market opens on Friday, February 28, 2025. Management will host a conference call ...

Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...

Start-up accelerators are designed to rapidly scale early-stage companies through mentorship, funding and resources.

ELMSFORD, N.Y. - NanoVibronix , Inc. (NASDAQ:NAOV), a medical device company with a current market capitalization of $2.25 million, has announced the acquisition of ENvue Medical (TASE:PMCN) Holdings ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...

UX and UI designers work closely with engineers throughout product development to build and implement design concepts and ...

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...